GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (OTCPK:BETRF) » Definitions » FCF Yield %

BETRF (BetterLife Pharma) FCF Yield % : -15.79 (As of Dec. 13, 2024)


View and export this data going back to 2010. Start your Free Trial

What is BetterLife Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BetterLife Pharma's Trailing 12-Month Free Cash Flow is $-1.84 Mil, and Market Cap is $11.64 Mil. Therefore, BetterLife Pharma's FCF Yield % for today is -15.79%.

The historical rank and industry rank for BetterLife Pharma's FCF Yield % or its related term are showing as below:

BETRF' s FCF Yield % Range Over the Past 10 Years
Min: -51.86   Med: 0   Max: 0
Current: -15.79


BETRF's FCF Yield % is ranked worse than
57.2% of 1507 companies
in the Biotechnology industry
Industry Median: -13.02 vs BETRF: -15.79

BetterLife Pharma's FCF Margin % for the quarter that ended in Jul. 2024 was 0.00%.


BetterLife Pharma FCF Yield % Historical Data

The historical data trend for BetterLife Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma FCF Yield % Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.99 -10.47 -65.08 -11.20 -28.40

BetterLife Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.30 -22.09 -11.72 -26.11 -20.53

Competitive Comparison of BetterLife Pharma's FCF Yield %

For the Biotechnology subindustry, BetterLife Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's FCF Yield % falls into.



BetterLife Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BetterLife Pharma's FCF Yield % for the fiscal year that ended in Jan. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1.842 / 6.4862
=-28.40%

BetterLife Pharma's annualized FCF Yield % for the quarter that ended in Jul. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.731 * 4 / 14.24093
=-20.53%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BetterLife Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BetterLife Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.
Executives
Barbara-jean Anne Bormann-kennedy director, officer: President 1188 BROADWAY, SUITE 306, SOMERVILLE MA 02144
Moira Ong officer: Chief Financial Officer 2392 LAWSON AVENUE, WEST VANCOUVER A1 V7V 2E6
Hassan Salari director, 10 percent owner 1517 WEST 58TH AVENUE, VANCOUVER A1 V6P 1W6
Ahmad Doroudian director, officer: Chairman 1275 WEST 6TH AVENUE, VANCOUVER A1 V6H 1A6